美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
46708-332-30	46708-332	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Limited	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-332-30)
46708-332-31	46708-332	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Limited	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-332-31)
46708-332-91	46708-332	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Limited	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-332-91)
46708-333-30	46708-333	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Limited	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-30)
46708-333-31	46708-333	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Limited	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-31)
46708-333-91	46708-333	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Limited	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-91)
62332-333-30	62332-333	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-333-30)
62332-333-31	62332-333	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-333-31)
62332-333-91	62332-333	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-333-91)
62332-332-30	62332-332	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-332-30)
62332-332-31	62332-332	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-332-31)
62332-332-91	62332-332	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606	N/A	ANDA	ANDA210341	Alembic Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-332-91)